Privia Health Group, Inc. Form 8-K Summary
Reporting date: June 23, 2023, with the report filed June 29, 2023. The filing concerns executive transition, director appointments and resignations, and related compensation arrangements. It does not include financial statements or operating results for a reporting period.
Business Context and Governance Changes
- Shawn Morris is retiring as Chief Executive Officer effective July 1, 2023 and will continue as a non-employee director.
- Parth Mehrotra, previously President and Chief Operating Officer, will become Chief Executive Officer effective July 1, 2023 and was appointed a Class II director.
- Adam Boehler was appointed a Class III director effective July 1, 2023. The Board determined that he is independent under Nasdaq and SEC standards.
- Will Sherrill resigned from the Board and from the Compensation and Nominating and Corporate Governance Committees, effective July 1, 2023. The resignation was not due to a disagreement with the Company.
- Mr. Morris was appointed to the Board’s Compliance Committee effective July 1, 2023.
Compensation and Other Financial Terms
- Beginning July 1, 2023, Mr. Mehrotra’s annual base salary will be $600,000, with a target annual bonus opportunity equal to 100% of base salary.
- Mr. Mehrotra will receive an incremental 2023 long-term incentive award valued at $1 million at grant date: 60% performance stock units and 40% restricted stock units.
- Mr. Mehrotra will also receive a special performance stock unit award valued at $6 million at target, based solely on relative total shareholder return over July 1, 2023 through June 30, 2027. Payout may range from 50% to 200% of the granted units once threshold performance is achieved.
- Mr. Morris may receive a pro rata 2023 performance bonus for January 1 through June 30, 2023, based on actual achievement and payable in 2024, subject to the agreement’s conditions.
- The Company will pay its portion of COBRA premiums for Mr. Morris for 12 months following July 1, 2023, subject to the transition agreement.
- Mr. Morris’s pre-July 1, 2023 equity awards will remain outstanding and continue vesting under their existing terms while he remains on the Board. He will not receive additional equity compensation under the non-employee director program while holding unvested awards.
- Mr. Boehler will be eligible for director compensation, including restricted stock units valued at $200,000 on July 1, 2023, unless he elects to waive compensation.
- In May 2023, an entity controlled by Rubicon Founders, whose managing partner is Mr. Boehler, purchased 5,318,182 shares of Privia common stock for $117 million.
Material Changes, Outlook, and Risks
- The principal change is the planned CEO succession from Mr. Morris to Mr. Mehrotra, effective July 1, 2023.
- The filing provides no revenue, profit, cash flow, margin, debt, liquidity, or operating guidance figures.
- The new CEO’s compensation includes substantial performance-based equity tied to company performance and relative shareholder returns, which may create future share-based compensation expense and dilution; the filing does not provide the number of shares or units awarded.
- Mr. Morris’s continued Board service, ongoing vesting of prior awards, potential bonus, and COBRA benefits create continuing compensation obligations.
- The filing does not identify additional operational contingencies or changes to the Company’s business outlook.
Key Facts for Investors to Verify
- Confirm the July 1, 2023 effective date and subsequent execution of the CEO transition.
- Review the Mehrotra Fourth Amendment to the Employment Agreement and the Relative TSR PSU Agreement filed as Exhibits 10.1 and 10.2.
- Assess the potential dilution and expense associated with the $1 million incremental award and $6 million target special PSU award.
- Review the Morris Transition Agreement, including continued vesting, bonus eligibility, COBRA payments, and post-service option exercise provisions.
- Evaluate the governance and related-party implications of Mr. Boehler’s appointment and Rubicon Founders’ $117 million share purchase.